While a good deal is known about the molecules that drive specification of the pharynx primordium, comparatively less is known about the morphogenetic and differentiation events that subsequently transform this primordium into the bilobed pharynx. To learn more about these processes, we are investigating a mutant called
pel-2(pharynx and elongation defective) that is blocked in pharynx development between the early and late stages. Unlike the
pha-4/FoxA and
pha-1/bZip mutants, which are completely defective in pharynx formation and pharynx differentiation/morphogenesis respectively, the
pel-2 mutant is only partially blocked in these processes, and is also fails to undergo overall elongation of the animal during morphogenesis. To form the pharynx primordium, the organ-specific selector gene
pha-4 acts on disparate cells types to activate transcription of pharynx-specific genes. We have found that
pha-4 is expressed at greatly reduced levels at all stages of pharynx development in
pel-2 animals, suggesting that PEL-2 is required for transcriptional activation of
pha-4. Furthermore, expression of a
myo-2 reporter driven by a
pha-4-dependent enhancer is drastically reduced in
pel-2 mutant embryos, supporting the hypothesis that high levels of
pha-4 expression are required to activate late-acting pharyngeal genes such as
myo-2. Consistent with this observation, we have found that differentiated pharynx gland and marginal cells are diminished in number, or eliminated, while early muscle markers are unaffected. These findings support a model in which
pel-2 acts on both
pha-4 and
pha-1 to complete pharyngeal differentiation and morphogenesis. When expression of a selector protein such as PHA-4 is altered, cell fate transformations often occur. Indeed, analysis of epidermal markers, including reporters for
mel-11 and
let-502, suggest that pharyngeal cells in
pel-2 mutants are partially transformed into an ectodermal cell fate. Curiously, the normal expression of these genes in the epidermis is greatly reduced or abolished, indicating a reciprocal effect of
pel-2 on activation and repression of their expression in the epidermis and pharynx respectively. The failure to express these genes in the epidermis may explain the elongation defect; indeed, terminal
pel-2 embryos arrest at a similar stage in elongation to that of
let-502 and
mel-11 mutants. We have rescued the
pel-2 mutant with a YAC clone and are currently identifying a minimal rescuing gene.